^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Progesterone receptor agonist

22h
IKanEat: a Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children (clinicaltrials.gov)
P4, N=71, Active, not recruiting, University of Kansas Medical Center | Recruiting --> Active, not recruiting
Enrollment closed
|
megestrol
5d
Impact of oral raceanisodamine Tablets during endometrial preparation in frozen-thawed embryo transfer cycle:a clinical prospective, randomized,double-blinded placebocontrolled trial (ChiCTR2400089254)
P=N/A, N=398, Not yet recruiting, Reproductive Medicine Center,Renmin Hospital,Hubei University of Medicine,Shiyan,People's Republic of China; Shiyan Renmin Hospital
New trial
5d
Research on the impact of progesterone on the periodontal microbiota and periodontal tissues (ChiCTR2400089666)
P4, N=60, Completed, Shengli Oilfield Central Hospital; Shengli Oilfield Central Hospital
New P4 trial
14d
New P1 trial
14d
Trial completion
17d
Contraceptive Hormones, Immunity, and Microbiome Evaluation (clinicaltrials.gov)
P=N/A, N=155, Completed, Emory University | Recruiting --> Completed | N=225 --> 155
Trial completion • Enrollment change
|
CD4 (CD4 Molecule) • CCR5 (C-C Motif Chemokine Receptor 5)
|
CCR5 expression
17d
LACTO-Rod: Breastfeeding Etonogestrel Implant Study (clinicaltrials.gov)
P4, N=150, Completed, University of New Mexico | Trial completion date: Dec 2024 --> Sep 2024 | Trial primary completion date: Dec 2024 --> Jun 2024 | Active, not recruiting --> Completed
Trial completion • Trial completion date • Trial primary completion date
19d
Deer Blood Hydrolysate Protects against D-Galactose-Induced Premature Ovarian Failure in Mice by Inhibiting Oxidative Stress and Apoptosis. (PubMed, Nutrients)
To sum up, the present research indicated that DBH can ameliorate D-gal-induced oxidative stress and apoptosis by regulating the Nrf2/HO-1 signalling pathway and the Bcl-2/Bax/caspase-3 apoptosis pathway, which can be used for further development as a nutraceutical product to improve premature ovarian failure.
Preclinical • Journal • IO biomarker
|
KEAP1 (Kelch Like ECH Associated Protein 1) • HMOX1 (Heme Oxygenase 1) • CASP3 (Caspase 3)
|
HMOX1 expression • KEAP1 expression
19d
Myo-Inositol and D-Chiro-Inositol Reduce DHT-Stimulated Changes in the Steroidogenic Activity of Adult Granulosa Cell Tumors. (PubMed, Int J Mol Sci)
For this purpose, we analyzed the mRNA expression of steroidogenic genes and the secretion of progesterone (P4) and 17β-estradiol (E2) in an unstimulated and/or dihydrotestosterone (DHT)-stimulated environment under MI and DCI influence...These findings suggest that CYP11A1 is responsible for the antiestrogenic effect of DCI in the androgen-rich environment of AGCTs. Therefore, MI and DCI could be used as effective agents in the adjuvant treatment of AGCT, but further detailed studies are needed.
Journal
|
STAR (Steroidogenic Acute Regulatory Protein)
21d
HSF1/HSP25 system protects mitochondria function from heat stress and assists steroidogenesis in MA-10 Leydig cells. (PubMed, Mol Cell Endocrinol)
HSP25 knockdown reduces MMP under heat stress conditions and decreases StAR protein levels and progesterone synthesis. HSP25 overexpression in HSF1KO cells restored StAR protein levels. These results show that the HSF1/HSP25 pathway protects mitochondrial function and maintains StAR synthesis.
Journal
|
HSPB1 (Heat shock 27kDa protein 1) • HSPH1 (Heat Shock Protein Family H (Hsp110) Member 1) • HSF1 (Heat Shock Transcription Factor 1)
|
HSPB1 expression
28d
A positive ReceptivaDx result for BCL6 does not correlate with abnormal ERA results or decreased expression of receptivity-associated markers: two sides of the endometrial receptivity coin in fertility evaluation and treatment. (PubMed, F S Sci)
A positive ReceptivaDx BCL6 result does not correlate with a pre-receptive ERA. Epithelial cells from BCL6-positive endometrium did not show significantly decreased expression in most of the receptivity markers evaluated. These findings demonstrate discordance between the interpretation of "endometrial receptivity" by ReceptivaDx and ERA, and highlight the need for further validation of endometrial evaluation methods in fertility treatment.
Journal
|
BCL6 (B-cell CLL/lymphoma 6)
|
BCL6 positive
28d
Proteogenomic Landscape of Breast Ductal Carcinoma Reveals Tumor Progression Characteristics and Therapeutic Targets. (PubMed, Adv Sci (Weinh))
In addition, AKR1C1 is identified as a potential therapeutic target and demonstrated the inhibitory effect of aspirin and dydrogesterone as its inhibitors on tumor cells. The integrative multi-omics analysis helps to understand the progression of BRDC and provides an opportunity to treat BRDC in different stages.
Journal
|
ER (Estrogen receptor) • TP53 (Tumor protein P53) • AR (Androgen receptor) • AKR1C1 (Aldo-Keto Reductase Family 1 Member C1) • TIAM1 (TIAM Rac1 Associated GEF 1) • NR3C1 (Nuclear Receptor Subfamily 3 Group C Member 1)
|
TP53 mutation • NR3C1 overexpression
|
aspirin
30d
COMPROSET: Progesterone-modified Natural Cycle for FET (clinicaltrials.gov)
P3, N=336, Not yet recruiting, Shandong University of Traditional Chinese Medicine
New P3 trial
1m
Site specific O-GlcNAcylation of progesterone receptor (PR) supports PR attenuation of interferon stimulated genes (ISGs) and tumor growth in breast cancer. (PubMed, J Biol Chem)
Furthermore, O-GlcNAcylation of PR enhances PR-driven tumor growth in vivo. We have delineated one contributing mechanism to PR function in breast cancer that impacts tumor growth, and provided additional insight into the mechanism through which PR attenuates interferon signaling.
Journal
|
ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HR positive • PGR expression
1m
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors. (PubMed, ESMO Open)
Leptin is a reliable predictive marker for multitargeted anti-cachectic treatment outcomes. Thus, it can be an ideal candidate for monitoring and predicting the effects of anti-cachectic treatment and a surrogate marker of the immune-metabolic actions of the selected drugs.
Journal
|
LEP (Leptin)
|
megestrol • celecoxib oral
1m
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia (clinicaltrials.gov)
P2, N=38, Recruiting, Peking University People's Hospital | Trial completion date: Feb 2025 --> Jun 2025
Trial completion date
|
medroxyprogesterone • atorvastatin
1m
Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients (clinicaltrials.gov)
P4, N=362, Active, not recruiting, CRG UZ Brussel | Recruiting --> Active, not recruiting | N=522 --> 362
Enrollment closed • Enrollment change
|
estradiol valerate
1m
New P1 trial
1m
PROGENDO: Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters (clinicaltrials.gov)
P4, N=108, Recruiting, Instituto Valenciano de Infertilidad, IVI VALENCIA | Trial completion date: Dec 2024 --> Dec 2025 | Trial primary completion date: Dec 2023 --> Dec 2025
Trial completion date • Trial primary completion date
1m
Steroidogenic differentiation of human amniotic membrane-derived mesenchymal stem cells into a progesterone-/androgen-producing cell lineage by SF-1 and an estrogen-producing cell lineage by WT1-KTS. (PubMed, Front Endocrinol (Lausanne))
Our findings revealed that SF-1 and WT1-KTS play important roles in human gonadal steroidogenic cell differentiation, especially during ovarian development. These findings may pave the way for future studies on human ovarian differentiation and development.
Preclinical • Journal
|
WT1 (WT1 Transcription Factor)
2ms
The Possible Role of Progesterone Receptors in Prostate Cancer Incidences in the Iraqi Population. (PubMed, Front Biosci (Schol Ed))
Many factors may play a role in PCa manifestation, with steroids and progesterone initially noted as factors. Many studies have dealt with the hormonal effect on PCa; however, few have ultimately determined the molecular impact on disease progression. The presence of pathogenic SNPs in the enhancing region of the gene may impact the expression level of PGR. High or low expression levels may negatively affect gene function, which can be considered a reliable factor in prostate tumorigenesis.
Journal
|
PGR (Progesterone receptor)
|
PGR expression
2ms
LO-COCO: LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions (clinicaltrials.gov)
P=N/A, N=100, Recruiting, Federico II University | Trial completion date: Jan 2024 --> Jan 2026 | Trial primary completion date: Jan 2024 --> Jan 2025
Trial completion date • Trial primary completion date
2ms
HormoSenoRec: Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation (clinicaltrials.gov)
P=N/A, N=60, Recruiting, Fundación IVI | Trial completion date: Jun 2024 --> Dec 2024 | Trial primary completion date: Jun 2024 --> Dec 2024
Trial completion date • Trial primary completion date
|
KIT (KIT proto-oncogene, receptor tyrosine kinase) • VEGFA (Vascular endothelial growth factor A) • IL6 (Interleukin 6) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • CD34 (CD34 molecule) • TGFB1 (Transforming Growth Factor Beta 1) • CD31 (Platelet and endothelial cell adhesion molecule 1) • PECAM1 (Platelet And Endothelial Cell Adhesion Molecule 1) • SMAD3 (SMAD Family Member 3)
2ms
Efficacy and safety of dienogest on ovarian endometrioma (PubMed, Zhonghua Fu Chan Ke Za Zhi)
During the follow-up period, there were a few patients with changes in the growth sites or lesion category of the breast nodules, but there were no occurrence of breast cancer or precancerous lesions. Dienogest is effective in reducing OMA volume and alleviating endometriosis-related pain with few adverse effects.
Journal
|
CA 19-9 (Cancer antigen 19-9)
2ms
Neuregulin 1 signaling attenuates tumor necrosis factor-α induced female rat luteal cell death. (PubMed, Endocrinology)
The corpus luteum (CL) is a transient ovarian endocrine structure that maintains pregnancy in primates during the first trimester and in rodents during the entire pregnancy by producing steroid hormone progesterone (P4)...Further analysis demonstrated that the phosphorylation status of ErbB2/3, PI3K, Akt, and ErK1/2 was significantly inhibited under these experimental conditions, whereas the treatment of TNFα further inhibited the phosphorylation of ErbB2/3, PI3K, Akt, and ErK1/2. Collectively, these studies provide new insights into the NRG1-mediated immunomodulatory and prosurvival role in LCs, which may maintain the function of CL.
Preclinical • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • NRG1 (Neuregulin 1) • TNFA (Tumor Necrosis Factor-Alpha) • EGF (Epidermal growth factor) • STAR (Steroidogenic Acute Regulatory Protein)
2ms
Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant (clinicaltrials.gov)
P4, N=114, Completed, University of Sao Paulo | Recruiting --> Completed
Trial completion
2ms
PROGRESS: Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer. (clinicaltrials.gov)
P3, N=680, Recruiting, IBSA Institut Biochimique SA | Trial completion date: Mar 2025 --> Apr 2026 | Trial primary completion date: Sep 2024 --> Aug 2025
Trial completion date • Trial primary completion date
2ms
New Cytotoxic α-Aminoacylamide and bis-1,5-Disubstituted Tetrazole Adducts From Amino-Diterpene Molecules by Ugi Reaction. (PubMed, Chem Biol Drug Des)
The NCI-60 cancer cell panel screening revealed diterpene-type Ugi adducts 2, 5, and 6 with strong antiproliferative potency with GI50 in range of 1.2-15.4 μM. The high positive correlations with standard anticancer drugs suggest microtubules or progesterone and androgen receptors as possible targets of the synthesized compounds.
Journal
|
AR (Androgen receptor)
2ms
Regulation of corticosteroid-binding globulin release in murine Leydig tumor cell line mLTC-1 by luteinizing hormone and interleukin-6. (PubMed, Arch Biochem Biophys)
In addition, secretory proteomic analysis indicated that the extracellular matrix (ECM), cytoskeleton, and proteasomes were essentially produced by the mLTC-1 cells, and LH evoked the secretion of proteins involved in binding and metabolism. These results emphasize that Leydig cells may undertake more functions than just steroidogenesis, and the regulation of Leydig cells by LH is versatile.
Preclinical • Journal • Tumor cell
|
IL6 (Interleukin 6)
2ms
Knock-out of CD73 delays the onset of HR-negative breast cancer by reprogramming lipid metabolism and is associated with increased tumor mutational burden. (PubMed, Mol Metab)
CD73 has a significant role in tumorigenesis driving the reprogramming of lipid metabolism through the regulatory loop with PR and PPARγ in epithelial cells of mammary glands. Low CD73 expression/CD73 KO might enhance mutational burden by disrupting this regulatory loop, delaying the onset of HR-negative tumors. Our results support combining therapy targeting the CD73-adenosine axis and tumor lipidome against HR-negative tumors, especially at their earliest developmental stage.
Journal • Tumor mutational burden
|
ER (Estrogen receptor) • PGR (Progesterone receptor) • TMB (Tumor Mutational Burden) • MLH1 (MutL homolog 1) • CD73 (5'-Nucleotidase Ecto) • GSTP1 (Glutathione S-transferase pi 1) • NT5E (5'-Nucleotidase Ecto) • PPARG (Peroxisome Proliferator Activated Receptor Gamma)
|
CD73 expression • CD73 underexpression • PGR expression • PGR negative
2ms
MOON: Mild versus conventional ovarian stimulation in expected normal ovarian responders undergoing IVF/ICSI-ET: a multicenter, open-label, parallel-group, randomized controlled trial (ChiCTR2400082894)
P=N/A, N=2202, Not yet recruiting, Women's Hospital, School of Medicine, Zhejiang University; Women's Hospital, School of Medicine, Zhejiang University | Initiation date: May 2024 --> Aug 2024
Trial initiation date
2ms
A prospective, randomised controlled study of retention enema-assisted treatment of uterine adhesions with Chinese medicine (ChiCTR2400087131)
P=N/A, N=290, Not yet recruiting, Peking University Third Hospital; Peking University Third Hospital
New trial
|
estradiol valerate
2ms
A multicenter, randomized, double-blind, placebo-controlled, parallel-design phase III clinical study to evaluate the efficacy and safety of oral relugoli tablets in the treatment of heavy menstrual bleeding associated with uterine fibroids (ChiCTR2400088811)
P3, N=120, Not yet recruiting, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences; Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
New P3 trial
|
medroxyprogesterone • estradiol valerate
2ms
Study on the effects of intestinal bacteria transplantation on glycolipid metabolism and body composition in patients with polycystic ovary syndrome (ChiCTR2400087346)
P1, N=84, Recruiting, Beijing Obstetrics and Gynecology Hospital, Capital Medical University; Beijing Obstetrics and Gynecology Hospital, Capital Medical University
New P1 trial
2ms
Expression of Endometrial Receptivity Markers throughout the Menstrual Cycle in Women with and without Uterine Adenomyosis. (PubMed, J Clin Med)
Immunohistochemistry was performed to evaluate the expression of markers of endometrial receptivity, namely the progesterone receptor (PR), glycodelin, leukemia inhibitory factor (LIF), homeobox A10 (HOXA10), integrin beta chain beta 3 (integrin β3) and osteopontin...The stromal compartment appears to be affected most, showing reduced expression of PR, LIF and osteopontin in the secretory phase and lower levels of HOXA10 during both proliferative and secretory phases. Decreased receptivity due to impaired stromal decidualization may contribute to poor reproductive outcomes in adenomyosis patients.
Journal
|
PGR (Progesterone receptor) • SPP1 (Secreted Phosphoprotein 1) • HOXA10 (Homeobox A10) • LIF (LIF Interleukin 6 Family Cytokine)
|
PGR expression
2ms
New trial
2ms
R-954, a bradykinin B1 receptor antagonist, as a potential therapy in a preclinical endometriosis model. (PubMed, Peptides)
The administration of R-954 or progesterone, for 15 consecutive days, prevented the progression of cyst development, reduced the size and weight of the cysts...In addition, treatment with the antagonist did not interfere in the females' estrous cycle, as well as prevented gestational losses (reduction in the number of intermediate resorptions in pregnant females with endometriosis). Data suggested that R-954 has anti-inflammatory and anti-angiogenic effects; does not influence the estrous cycle; and prevents the number of gestational losses suggesting it as a good candidate for endometriosis treatment.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
2ms
High Levels of Superoxide Dismutase 2 Are Associated With Worse Prognosis in Patients With Breast Cancer. (PubMed, Eur J Breast Health)
Significant differences were observed between SOD2 expression analyzed by IHC, and estrogen (p = 0.0008) and progesterone (p = 0.0003) receptors, as well as tumor subtypes (p<0.0001)...These results highlight the importance of SOD2 in breast cancer, particularly in aggressive subtypes. Increased SOD2 staining correlates with poorer outcomes, suggesting it as a potential therapeutic target.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • SOD2 (Superoxide Dismutase 2)
|
HER-2 expression
3ms
Promoting effect of Sunset Yellow on N-methyl N-nitrosourea-induced rat mammary carcinogenesis: Implications of molecular mechanisms. (PubMed, Toxicol Lett)
Collectively, SY has significantly promoted MNU-induced mammary tumors in rats with underlying mechanisms correlating SY consumption with estrogen disruption and subsequent antioxidative stress discrepancy.
Preclinical • Journal
|
ER (Estrogen receptor) • PGR (Progesterone receptor) • EGF (Epidermal growth factor) • PCNA (Proliferating cell nuclear antigen)
3ms
New trial
3ms
Progesterone improves motor coordination impairments caused by postnatal hypoxic-ischemic brain insult in neonatal male rats. (PubMed, Pediatr Neonatol)
P4 administration restored motor coordination impairments caused by postnatal HI insult in male rats. The insult timing corresponds to that of human preterm infants, indicating P4's potential for protecting HI brain injury in preterm male infants.
Preclinical • Journal
|
OLIG2 (Oligodendrocyte Transcription Factor 2)